High-Efficiency Bohle Tablet Coater

News
Article

L.B. Bohle has developed the future of tablet coating, the high-efficiency Bohle Tablet Coater (BTC). The tablet coater reduces processing times up to 35 percent compared to conventional tablet coating systems, yielding significant cost savings and improved campaign efficiency while maintaining cGMP standards.

The BTC provides superior coating uniformity, producing considerably fewer rejects and using less coating material. L.B. Bohle’s patented air flow bed technology eliminates spray drying, thereby reducing waste while lengthening campaigns between cleaning. It also promotes uniform tablet coating with a high-quality, defect-free film coat.

The tablet coater’s elongated coating pan provides a larger tablet spraying surface accommodating up to 10 spray nozzles, which delivers more suspension solution and reduces overall coating time. The BTC’s integrated mixing baffles are double-helix shaped to ensure thorough tablet mixing with gentle handling. The baffle design provides 100-percent tablet discharge, increasing campaign efficiency.

The BTC is ergonomically designed for efficient material handling and is capable of Wash-in-Place (WIP) cleaning. The BTC spray arm and nozzles are mounted on the front door assembly, simplifying inspection and maintenance.

 

The L.B. Bohle Coating products:

  • Bohle Tablet Coater BTC

  • Bohle Film Coater BFC TriPan

  • Bohle Film Coater BFC

Contact:
Tobias Borgers
Head of Marketing
Phone: +49 25 24 - 93 23 0
Fax: +49 25 24 - 93 23 399
Email: t.borgers@lbbohle.de
Web: www.lbbohle.com

Recent Videos
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Drug Digest: Challenges and Triumphs in Next-Generation Biotherapeutic Development
Adam Sherlock, CEO of Qinecsa, discusses the changing political landscapes in the US and Europe and how that may affect the bio/pharma industry.
Related Content